Matthew holds science degrees in Zoology (BSc hons, University of Otago, NZ) and Natural resource management (MSc hons, Canterbury University, NZ) and a post graduate diploma in Health Economics (Dip. Health Econ., University of Tromso, Norway). His professional background includes 17 years in senior public sector positions in New Zealand and Canada including 3 years as Vice President of CADTH (Canada’s health technology assessment agency) and 5 years as Chief Executive of PHARMAC (New Zealand’s universal drug benefit program). He is an expert in the scientific, economic and financial analysis essential for efficient and equitable allocation of public and private resources and has applied this expertise primarily to the health sector – in particular, pharmaceutical benefit program management and design. Establishing himself as an independent consultant in 2014 and an exclusive Senior Consultant with Analytica (Certara) since 2016, he has worked as an expert advisor for many clients in the area of market access and reimbursement of pharmaceuticals where they have called upon his primary expertise in assessing value and value for money of health technologies.